Orchestra BioMed Holdings (OBIO) Shares Issued (2022 - 2026)
Orchestra BioMed Holdings (OBIO) reported Shares Issued of $5.9 million for Q1 2026, up 6334.07% year-over-year from $91000.0 in Q1 2025, and up 6334.07% on a QoQ basis from $91000.0 in Q1 2025.
Orchestra BioMed Holdings (OBIO) has 5 years of Shares Issued data on file, last reported at $5.9 million in Q1 2026.
- Quarterly Shares Issued rose 6334.07% year-over-year to $5.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.9 million (up 1770.61% YoY) and the FY2025 annual result came in at $91000.0, down 62.08% from the prior year.
- Shares Issued improved to $5.9 million in Q1 2026 per OBIO's latest filing, from $91000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $14.8 million in Q3 2024 and bottomed at -$14.8 million in Q4 2024.
- The 5-year median for Shares Issued is $48000.0 (2022), against an average of $544833.3.
- The widest annual swing landed in 2024, when Shares Issued tumbled 7212.98%; it then surged 6334.07% in 2026.
- Tracing OBIO's Shares Issued over 5 years: stood at $42000.0 in 2022, then surged by 395.24% to $208000.0 in 2023, then plunged by 7212.98% to -$14.8 million in 2024, then surged by 100.62% to $91000.0 in 2025, then surged by 6334.07% to $5.9 million in 2026.
- Per Business Quant, the three latest OBIO Shares Issued figures stand at $5.9 million (Q1 2026), $91000.0 (Q1 2025), and -$14.8 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 5.40 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 27.00 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 163.10 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.16 Mn |
| 10 | Orchestra BioMed Holdings | 245.24 Mn | 255.02 Mn | 78,000.00 | 5.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.86 Mn |
| Mar 31, 2026 | 5.86 Mn |
| Mar 31, 2025 | 91,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | -14.80 Mn |
| Dec 31, 2024 | -14.80 Mn |
| Sep 30, 2024 | 14.85 Mn |
| Sep 30, 2024 | 14.85 Mn |
| Jun 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Dec 31, 2023 | 208,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Jun 30, 2022 | 54,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Mar 31, 2022 | 25,000.00 |